OSE Immunotherapeutics (France)

OSE Immunotherapeutics (France)

Open Access statistics for OSE Immunotherapeutics (France), France, covering academic research published from 2000 to 2023.

Open Access statistics for OSE Immunotherapeutics (France), France, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

66%


Total
Publications

113


Total Open
Publications

75


Total
Citations

2.1K


Open Access
Percentage

66%


Total
Publications

113


Total Open
Publications

75


Total
Citations

2.1K

Website

download

Breakdown

27% 34% 5% 34%

Publisher Open

27%

Both

34%

Other Platform Open

5%

Closed

34%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

42%OA Journal

OA Journal 42%

29

Hybrid 28%

19

No Guarantees 30%

21

Other Platform Open

Domain 80%

35

Institution 50%

22

Other Internet 36%

16

Preprint 9%

4

Public 9%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
35
Europe PMC
Domain
20
CCSD (Centre pour la Communication Scientifique Directe) - HAL - Nantes Université
Other Internet
12
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
10
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
9
Le Centre pour la Communication Scientifique Directe - HAL - Inserm
Institution
8
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
5
University of Cambridge - Apollo
Institution
4
Semantic Scholar
Public
4
Le Centre pour la Communication Scientifique Directe - HAL - CEA - Commissariat à l'Énergie Atomique
Institution
4
1 / 3

Data updated 8 December 2024

Share

Share

Share